2019-nCoV: Treating doctors face dilemma over steroids

The drugs did not help in the SARS and MERS outbreaks, they say

Evidence is urgently needed on whether corticosteroid therapy is appropriate for treating patients infected with the novel coronavirus (2019-nCoV) who are severely ill, pulmonary and critical-care clinicians say.

Patient with IV

Treating doctors in Wuhan say they face a dilemma because, while steroids may reduce inflammatory lung injury, the medication may delay viral clearance.

Like SARS and MERS before it, 2019-nCoV induces a cytokine storm that suggests corticosteroids would be appropriate,